pediatric steroid-refractory acute graft versus host disease

source: pixabay.com

The FDA Rejects New Drug for SR-aGVHD, Shocking Scientists and Patients

Post author:Sunniva Bean
Post published:October 28, 2020
Post category:Graft versus Host Disease Graft-versus-Host Disease

As reported in BioSpace, the FDA shocked Mesoblast executives, a stem-cell research company, when this October, they rejected the Biologics License Application (BLA) for the drug Ryoncil, meant to treat…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More